Abstracts tagged "SAPHO syndrome"

Abstract Number: 1248 • 2019 ACR/ARP Annual Meeting
Clinical Manifestations and Management of US Patients with SAPHO (Synovitis, Acne, Pustulosis, Hyperostosis, Osteitis) Syndrome, a Retrospective Study
Delamo Bekele¹, Paras Karmacharya ², Kerry Wright ² and Clement Michet ¹, ¹Mayo Clinic Rochester, Rochester, MN, ²Mayo Clinic, Rochester, MN
Background/Purpose: The SAPHO syndrome is a rare inflammatory disorder of bones, joints and skin first coined by Chamot in 1987 characterized by synovitis, acne, pustulosis,…
Abstract Number: 1259 • 2019 ACR/ARP Annual Meeting
Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis (SAPHO): A Case Series
Devanshu Verma¹, Samir Shah ² and Arundathi Jayatilleke ³, ¹Drexel University, Philadelphia, ²Thomas Jefferson University, Philadelphia, ³Drexel, Philadelphia, PA
Background/Purpose: SAPHO is a chronic multisystemic illness with predominantly skin and joint manifestations. Disease presentation is heterogenous; proposed diagnostic criteria include chronic multifocal aseptic osteomyelitis…
Abstract Number: 371 • 2017 ACR/ARHP Annual Meeting
Longer Term Outcomes of Chronic Relapsing Multifocal Osteomyelitis in a UK Tertiary Adolescent and Young Adult Rheumatology Centre
Kristina E.N. Clark¹, Francesca Josephs², Nicola Daly³, Claire Louise Murphy³ and Debajit Sen⁴, ¹Rheumatology, University college London Hospitals, London, United Kingdom, ²rhuematology, UCL, London, United Kingdom, ³Rheumatology, University College London Hospital, London, United Kingdom, ⁴Adolescent Rheumatology Department, University College London Hospital NHS Trust, London, United Kingdom
Background/Purpose: Chronic relapsing multifocal osteomyelitis (CRMO) is a rare autoinflammatory bone condition presenting primarily in children & adolescents. It characteristically affects the epiphysis & metaphysis…
Abstract Number: 1883 • 2017 ACR/ARHP Annual Meeting
Patterns of Osteoarticular Involvement in SAPHO Syndrome: A Cluster Analysis Based on Whole Body Bone Scintigraphy in 157 Patients
Yihan Cao¹, Chen Li², Ping Xu¹, Yueting Li¹, Qiao Yang¹ and Xiaochuan Sun¹, ¹Peking Union Medical College, Beijing, China, ²Peking Union Medical College Hospital, Beijing, China
Background/Purpose: The aim was to explore patterns of osteoarticular involvement in SAPHO syndrome using cluster analysis of lesions revealed by whole body bone scintigraphy. Methods:…
Abstract Number: 1367 • 2012 ACR/ARHP Annual Meeting
Clinical Features and Treatment Results of Japanese Patients with SAPHO (Synovitis-Acne-Pustulosis-Hyperostosis-Osteitis) Syndrome
Hiroki Yabe¹, Takashi Kuroiwa¹, Aya Nonaka¹, Tomomi Tsutsumi¹, Tadashi Sakurai¹, Masato Moriguchi¹, Hisaji Oshima², Kensuke Ochi³ and Chihiro Terai¹, ¹Division of Rheumatology, Jichi Medical University Saitama Medeical Center, Saitama City, Japan, ²Connective Tissue Diseases, Tokyo Medical Ctr, Tokyo, Japan, ³Department of Orthopaedic Surgery, Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan
Background/Purpose: SAPHO syndrome is a disorder characterized by pustular skin lesions and osteoarticular lesions, which was proposed by Chamot et al. in 1987. Clinical studies…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].